No black box warning on record for Quinidine Gluconate

As of the latest FDA labeling reviewed, Quinidine Gluconate (QUINIDINE GLUONATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Quinidine Gluconate medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Mortality: In many trials of antiarrhythmic therapy for non-life-threatening arrhythmias, active antiarrhythmic therapy has resulted in increased mortality; the risk of active therapy is probably greatest in patients with structural heart disease. In the case of quinidine used to prevent or defer recurrence of atrial flutter/fibrillation, the best available data come from a meta-analysis

No black box warning on record for Quinidine Gluconate

Other warnings & precautions

WARNINGS Mortality: In many trials of antiarrhythmic therapy for non-life-threatening arrhythmias, active antiarrhythmic therapy has resulted in increased mortality; the risk of active therapy is probably greatest in patients with structural heart disease. In the case of quinidine used to prevent or defer recurrence of atrial flutter/fibrillation, the best available data come from a meta-analysis

Quinidine Gluconate Black Box Warning

No black box warning on record for Quinidine Gluconate

Other warnings & precautions

Quinidine Gluconate Black Box Warning

No black box warning on record for Quinidine Gluconate

Other warnings & precautions